Benitec Stock Future Price Prediction


USD 0.17  0.02  10.53%   

Benitec Biopharma stock price prediction is an act of determining the future value of Benitec Biopharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Benitec Biopharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Benitec Biopharma and does not consider all of the tangible or intangible factors available from Benitec Biopharma's fundamental data. We analyze noise-free headlines and recent hype associated with Benitec Biopharma, which may create opportunities for some arbitrage if properly timed.
Continue to Benitec Biopharma Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Benitec Biopharma based on different types of headlines from major news networks to social media. The Benitec stock price prediction module provides an analysis of price elasticity to changes in media outlook on Benitec Biopharma over a specific investment horizon.
EPS Estimate Next Quarter
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Quarterly Revenue Growth YOY
Using Benitec Biopharma hype-based prediction, you can estimate the value of Benitec Biopharma from the perspective of Benitec Biopharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Benitec Biopharma using Benitec Biopharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Benitec using crowd psychology based on the activity and movement of Benitec Biopharma's stock price.

Benitec Biopharma Implied Volatility

Benitec Biopharma's implied volatility exposes the market's sentiment of Benitec Biopharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Benitec Biopharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Benitec Biopharma stock will not fluctuate a lot when Benitec Biopharma's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Benitec Biopharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Benitec Biopharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Benitec because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Benitec Biopharma after-hype prediction price

  USD 0.11  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Benitec Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Benitec Biopharma in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
Band Projection (param)
LowerMiddle BandUpper
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Benitec Biopharma. Your research has to be compared to or analyzed against Benitec Biopharma's peers to derive any actionable benefits. When done correctly, Benitec Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Benitec Biopharma.

Benitec Biopharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Benitec Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Benitec Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Benitec Biopharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Benitec Biopharma Estimiated After-Hype Price Volatility

In the context of predicting Benitec Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Benitec Biopharma's historical news coverage. Benitec Biopharma's after-hype downside and upside margins for the prediction period are 0.01 and 8.73, respectively. We have considered Benitec Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 0.17
After-hype Price
Benitec Biopharma is out of control asset. Analysis and calculation of next after-hype price of Benitec Biopharma is based on 3 months time horizon.

Benitec Biopharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Benitec Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Benitec Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Benitec Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.57  8.62   0.06    2.52  3 Events / Month4 Events / MonthIn about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Benitec Biopharma Hype Timeline

Benitec Biopharma is currently traded for 0.17. The entity has historical hype elasticity of -0.06 and average elasticity to hype of competition of -2.52. Benitec is anticipated to decline in value after the next headline with the price expected to drop to 0.11. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -35.29% whereas the daily expected return is currently at -1.57%. The volatility of related hype on Benitec Biopharma is about 537.31% with expected price after next announcement by competition of -2.35. About 58.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.36. Some equities with similar Price to Book (P/B) outperform the market in the long run. Benitec Biopharma recorded a loss per share of 2.17. The entity last dividend was issued on the 18th of November 2019. The firm had 2:3 split on the 15th of April 2020. Given the investment horizon of 90 days the next anticipated press release will be in about 3 days.
Continue to Benitec Biopharma Basic Forecasting Models to cross-verify your projections.

Benitec Biopharma Related Hype Analysis

Having access to credible news sources related to Benitec Biopharma's direct competition is more important than ever and may enhance your ability to predict Benitec Biopharma's future price movements. Getting to know how Benitec Biopharma rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Benitec Biopharma may potentially react to the hype associated with one of its peers.

Benitec Biopharma Additional Predictive Modules

Most predictive techniques to examine Benitec price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Benitec using various technical indicators. When you analyze Benitec charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Benitec Biopharma Predictive Indicators

The successful prediction of Benitec Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Benitec Biopharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Benitec Biopharma based on analysis of Benitec Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Benitec Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Benitec Biopharma's related companies.

Story Coverage note for Benitec Biopharma

The number of cover stories for Benitec Biopharma depends on current market conditions and Benitec Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Benitec Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Benitec Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Benitec Biopharma Short Properties

Benitec Biopharma's future price predictability will typically decrease when Benitec Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Benitec Biopharma often depends not only on the future outlook of the potential Benitec Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Benitec Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding8171690.00
Cash And Short Term Investments4062000.00
Continue to Benitec Biopharma Basic Forecasting Models to cross-verify your projections. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for analysis

When running Benitec Biopharma price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bond Directory
Find actively traded corporate debentures issued by US companies
Equity Valuation
Check real value of public entities based on technical and fundamental data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Benitec Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.3 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Benitec Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.